Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2012-02-29

View Filing

D - Notice of Exempt Offering of Securities

Form Type: D

Filing Date: 2012-02-24

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2012-02-07

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2012-02-06

View Filing

S-1 - General form for registration of securities under the Securities Act of 1933

Form Type: S-1

Filing Date: 2012-01-27

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2012-01-26

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2012-01-05

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2011-12-20

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2011-12-16

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-12-09

View Filing